|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.67 CNY | -12.38% |
|
-7.75% | +9.30% |
| 07-13 | ApicHope Pharmaceutical Receives Shareholder Proposal from Hanxiong Li | CI |
| 06-11 | China Approves ApicHope Subsidiary's Clinical Trials for Leukemia Drug | MT |
| Market Cap | 16.45B 2.43B 2.12B 1.96B 1.8B 3.4B 234B 3.48B 23.39B 9.2B 114B 9.11B 8.91B 394B | P/E 2026 * |
31.6x | P/E 2027 * | -159x |
|---|---|---|---|---|---|
| Enterprise Value | 16.45B 2.43B 2.12B 1.96B 1.8B 3.4B 234B 3.48B 23.39B 9.2B 114B 9.11B 8.91B 394B | EV / Sales 2026 * |
15.2x | EV / Sales 2027 * | 13.1x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -12.38% | ||
| 1 week | -7.75% | ||
| Current month | -1.64% | ||
| 1 month | +9.72% | ||
| 3 months | +0.25% | ||
| 6 months | -0.78% | ||
| Current year | +9.30% |
| 1 week | 35.84 |  | 43.5 |
| 1 month | 31.37 | | 44.8 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 81.48 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Jian Zhang
BRD | Director/Board Member | 70 | 01/07/2024 |
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.38% | -7.75% | -45.36% | +33.35% | 2.43B | |
| +0.60% | +1.07% | +14.76% | +76.92% | 48.15B | |
| -0.23% | -1.65% | +67.15% | +109.36% | 35.59B | |
| +1.80% | +1.11% | -2.12% | +36.54% | 11.9B | |
| +1.33% | +2.38% | +19.40% | +87.55% | 11.85B | |
| +0.93% | +2.87% | +34.92% | +137.61% | 9.31B | |
| +3.37% | -0.10% | +51.64% | -4.77% | 7.02B | |
| -0.75% | -0.91% | +17.45% | +36.14% | 6.91B | |
| -.--% | +0.14% | - | - | 6.79B | |
| -0.22% | -3.15% | +2.01% | +200.91% | 6.55B | |
| Average | -0.59% | -1.23% | +17.76% | +79.29% | 14.65B | |
| Weighted average by Cap. | +0.31% | -0.78% | +28.75% | +85.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 159M 139M 128M 118M 223M 15.34B 228M 1.54B 604M 7.51B 598M 585M 25.87B | 1.26B 186M 162M 150M 138M 260M 17.87B 266M 1.79B 704M 8.75B 697M 682M 30.13B |
| Net income | 526M 77.6M 67.82M 62.58M 57.68M 109M 7.47B 111M 748M 294M 3.66B 291M 285M 12.6B | -102M -15.05M -13.15M -12.14M -11.19M -21.08M -1.45B -21.55M -145M -57.05M -710M -56.51M -55.27M -2.44B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | CN¥36.67 | -12.38% | 21,128,034 |
| 16/07/26 | CN¥41.85 | +2.27% | 23,962,701 |
| 15/07/26 | CN¥40.92 | +0.52% | 27,558,495 |
| 14/07/26 | CN¥40.71 | +3.43% | 19,727,349 |
| 13/07/26 | CN¥39.36 | -0.98% | 18,154,135 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
